SCHEMBL18328443

SCHEMBL18328443

CCCCCCCCCCCC(=O)O/N=C1\COc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 3/20 0.39
POLM Q9NP87 1/20 0.39
POLK Q9UBT6 1/20 0.39
POLL Q9UGP5 1/20 0.39
POLH Q9Y253 1/20 0.39
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
PPARG P37231 1/20 0.37
SOAT1 P35610 2/20 0.36
ALOX5 P09917 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
NLRP3 Q96P20 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexanoate SCHEMBL4559406 0.66 AKR1B1 (0.50) ALDH1A1MEN1KMT2APPARGMAPT
SCHEMBL14315096 0.66 POLM (0.66) LMNAPOLMPOLKPOLLPOLH
SCHEMBL31174298 0.65 CES2 (0.54) L3MBTL1ALDH1A1MEN1KMT2ACES2
SCHEMBL27622884 0.65 SOAT2 (0.51) ALDH1A1MEN1KMT2ASOAT1CES2
SCHEMBL8670309 0.65 SOAT2 (0.51) ALDH1A1MEN1KMT2ASOAT1CES2
SCHEMBL21569218 0.65 SOAT2 (0.51) ALDH1A1MEN1KMT2ASOAT1CES2
SCHEMBL12609459 0.64 NOTUM (0.43) NPC1RAB9AGAALMNAL3MBTL1
SCHEMBL1266177 0.64 RAD52 (0.46) RAB9AGAALMNAL3MBTL1ALDH1A1
SCHEMBL11277949 0.63 CES2 (0.48) LMNAL3MBTL1MEN1KMT2APPARG
SCHEMBL15549264 0.63 KMT2A (0.66) LMNAPOLMPOLKPOLLPOLH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9751851-B2 Molecules and compositions that inhibit gram negative bacteria and their uses THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-09-05 US disclosed
US-9751851-B2 Molecules and compositions that inhibit gram negative bacteria and their uses THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-09-05 US disclosed
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-12-22 US disclosed
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES BLVRB, PGLS, GRHPR NPC1 4883/4885RAB9A 751/4885GAA 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.